Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
NCT06263010
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Allopregnanolone
Sponsor
Roberta Brinton